Sodium Hydroxide → N-(3-{6-[1-(4-Methoxybenzyl)-1H-pyrazol-4-yl]-1H-imidazo[1,2-b]pyrazol-1-yl}-4-methyl-phenyl)-3-(4-methylpiperazin-1-yl)-5-(pentafluoro-lambda6-sulphanyl)benzamide
반응식
F[C:2](F)(F)[C:3]([OH:5])=O.COC1C=CC([CH2:14][N:15]2[CH:19]=[C:18]([C:20]3[CH:21]=[C:22]4[N:27]([C:28]5[CH:29]=[C:30]([CH:32]=[CH:33][C:34]=5[CH3:35])[NH2:31])[CH:26]=[CH:25][N:23]4[N:24]=3)[CH:17]=[N:16]2)=CC=1.F[C:39](F)(F)C(O)=O.[CH3:45][N:46]1[CH2:51][CH2:50][N:49]([C:52]2[CH:53]=[C:54]([CH:58]=[C:59]([S:61]([F:66])([F:65])([F:64])([F:63])[F:62])[CH:60]=2)[C:55]([OH:57])=O)[CH2:48][CH2:47]1.CN(C(ON1N=N[C:77]2[CH:78]=[CH:79]C=N[C:76]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)C(C)C)(C)C.[OH-].[Na+]>CN(C=O)C>[CH3:39][O:5][C:3]1[CH:2]=[CH:79][C:78]([CH2:14][N:15]2[CH:19]=[C:18]([C:20]3[CH:21]=[C:22]4[N:27]([C:28]5[CH:29]=[C:30]([NH:31][C:55](=[O:57])[C:54]6[CH:58]=[C:59]([S:61]([F:62])([F:63])([F:65])([F:64])[F:66])[CH:60]=[C:52]([N:49]7[CH2:48][CH2:47][N:46]([CH3:45])[CH2:51][CH2:50]7)[CH:53]=6)[CH:32]=[CH:33][C:34]=5[CH3:35])[CH:26]=[CH:25][N:23]4[N:24]=3)[CH:17]=[N:16]2)=[CH:77][CH:76]=1참가 물질
7
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
70 mg (0.14 mmol) of the compound of Example 8A, 62.9 mg (0.14 mmol) of the compound of Example 17A and 62 mg (0.16 mmol) of HATU were dissolved in 0.79 ml of DMF, 0.07 ml (0.41 mmol) of N,N-diisopropylethylamine were added and the mixture was stirred at RT for 1 h. The mixture was then stirred into 10 ml of 0.1 M aqueous sodium hydroxide solution and stirred at RT for 10 min, and the precipitate formed was then filtered off. The solid was washed with water and dried under high vacuum. This gave 94 mg (94% pure, 89% of theory) of the title compound.
후처리
- stirringstirred at RT for 10 min
- customthe precipitate formed
- filtrationwas then filtered off
- washThe solid was washed with water
- customdried under high vacuum
출처 및 근거
- ORD 기록
- ord-80d46318b41c4c0c897b2fec4d9376a0
- 출처 데이터셋
- uspto-grants-2016_07
- 특허 번호
- US09394309B2
반응 노트
불러오는 중…